Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| TETRAPHASE PHARMACEUTICALS INC | 69,270 | reported | 14 Aug 2015 | tx 39+473,188−533,724 |
| Vor Biopharma Inc. | 30,000 | reported | 22 May 2025 | tx 5+123,811 |
| GLYCOMIMETICS INC | 9,023 | reported | 23 Jun 2025 | tx 1+9,023 |
| Arcellx, Inc. | 0 | reported | 28 Apr 2026 | tx 17+117,841−250,325 |
| Disc Medicine, Inc. | 0 | reported | 04 Oct 2021 | tx 5+118,629 |
| CARGO Therapeutics, Inc. | 0 | reported | 19 Aug 2025 | tx 4+73,742−25,000 |
| Nightstar Therapeutics plc | 0 | reported | 07 Jun 2019 | tx 4+21,000−68,324 |
| Ra Pharmaceuticals, Inc. | 0 | reported | 02 Apr 2020 | tx 16+378,952−584,172 |
| Therapeutics Acquisition Corp. | 0 | reported | 27 Dec 2023 | tx 9+98,963−134,363 |
| Dyne Therapeutics, Inc. | 0 | reported | 24 Apr 2026 | tx 12+388,544−231,497 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 Apr 2026 | TENDER | Arcellx, Inc. | 21,659 | — | |
| 28 Apr 2026 | OTHER | Arcellx, Inc. | 13,626 | — | deriv |
| 28 Apr 2026 | OTHER | Arcellx, Inc. | 59,405 | — | deriv |
| 28 Apr 2026 | OTHER | Arcellx, Inc. | 31,794 | — | deriv |
| 28 Apr 2026 | OTHER | Arcellx, Inc. | 61,538 | — | deriv |
| 28 Apr 2026 | OTHER | Arcellx, Inc. | 11,459 | — | deriv |
| 28 Apr 2026 | OTHER | Arcellx, Inc. | 8,011 | — | deriv |
| 28 Apr 2026 | OTHER | Arcellx, Inc. | 9,174 | — | deriv |
| 24 Apr 2026 | GIFT | Dyne Therapeutics, Inc. | 53,625 | 0.00 USD | |
| 20 Jan 2026 | SALE | Arcellx, Inc. | 6,000 | 75.00 USD | |
| 20 Jan 2026 | EXERCISE | Arcellx, Inc. | 6,000 | 6.28 USD | |
| 20 Jan 2026 | EXERCISE | Arcellx, Inc. | 6,000 | 0.00 USD | deriv |
| 19 Aug 2025 | OTHER | CARGO Therapeutics, Inc. | 25,000 | — | deriv |
| 23 Jun 2025 | GRANT_AWARD | GLYCOMIMETICS INC | 9,023 | 0.00 USD | deriv |
| 18 Jun 2025 | GRANT_AWARD | CARGO Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 30 May 2025 | GRANT_AWARD | Dyne Therapeutics, Inc. | 35,000 | 0.00 USD | deriv |
| 29 May 2025 | GRANT_AWARD | Arcellx, Inc. | 9,174 | 0.00 USD | deriv |
| 22 May 2025 | GRANT_AWARD | Vor Biopharma Inc. | 30,000 | 0.00 USD | deriv |
| 04 Jun 2024 | GRANT_AWARD | CARGO Therapeutics, Inc. | 23,742 | 0.00 USD | deriv |
| 28 May 2024 | GRANT_AWARD | Arcellx, Inc. | 8,011 | 0.00 USD | deriv |
| 23 May 2024 | GRANT_AWARD | Vor Biopharma Inc. | 30,000 | 0.00 USD | deriv |
| 22 May 2024 | GRANT_AWARD | Dyne Therapeutics, Inc. | 25,133 | 0.00 USD | deriv |
| 26 Dec 2023 | TENDER | Therapeutics Acquisition Corp. | 35,400 | — | |
| 27 Dec 2023 | OTHER | Therapeutics Acquisition Corp. | 3,600 | — | |
| 27 Dec 2023 | OTHER | Therapeutics Acquisition Corp. | 25,614 | — | deriv |
1 purchase reported after at least 12 months of silence — most recent on 23 Nov 2022.